Olimpia GES, Yolanda TF, Darío GH, Aracely DO, de Lourdes ZMMa, Nereyda HN et al (2017) Satisfaction of the service provider with the Organization of the Timely Cervical Cancer Detection Program. Health N Hav 09(02):289–298

Google Scholar 

El-Naggar AK, Chan JKC, Grandis JR (2017) World Health Organisation Classification of Head and Neck Tumors. In: World Health Organisation Classification of Head and Neck Tumors. 4th Edition. pp. 77–104

Obid R, Redlich M, Tomeh C (2019) The treatment of Laryngeal Cancer. Vol. 31, oral and maxillofacial surgery clinics of North America. W.B. Saunders, pp 1–11

Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF (2017) An update on larynx cancer. CA Cancer J Clin 67(1):31–50

Article  PubMed  Google Scholar 

Akdemir EY, Cengiz M Baş-Boyun Kanserlerinde Organ Koruyucu Kemoradyoterapi, Organ-Preserving Chemoradiation in Head and Neck Cancers, Türkiye Klinikleri Medical Oncology, Special Topics, 2018-Volume 11, pp. 147–153

Picon H, Guddati AK (2020) Mechanisms of resistance in head and neck cancer. Am J Cancer Res 10(9):2742–2751 PMID: 33042614; PMCID: PMC7539768

CAS  PubMed  PubMed Central  Google Scholar 

Mengie Ayele T, Tilahun Muche Z, Behaile Teklemariam A, Bogale Kassie A, Chekol Abebe E (2022) Role of JAK2/STAT3 signaling pathway in the Tumorigenesis, Chemotherapy Resistance, and treatment of solid tumors: a systemic review. J Inflamm Res 15:1349–1364. https://doi.org/10.2147/JIR.S353489

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spitzner M, Ebner R, Wolff HA, Michael Ghadimi B, Wienands J, Grade M (2014) STAT3: A novel molecular mediator of resistance to chemoradiotherapy. Vol. 6, Cancers. MDPI; pp. 1986–2011

Hu X, Li J, Fu M, Zhao X, Wang W (2021) The JAK/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402. https://doi.org/10.1038/s41392-021-00791-1

Article  PubMed  PubMed Central  Google Scholar 

Xin P, Xu X, Deng C, Liu S, Wang Y, Zhou X, Ma H, Wei D, Sun S (2020) The role of JAK/STAT signaling pathway and its inhibitors in diseases. Int Immunopharmacol 80:106210. https://doi.org/10.1016/j.intimp.2020.106210

Article  CAS  PubMed  Google Scholar 

Thomas SJ, Snowden JA, Zeidler MP, Danson SJ (2015) The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer 113(3):365–371. https://doi.org/10.1038/bjc.2015.233

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCarty KS Jr, Szabo E, Flowers JL, Cox EB, Leight GS, Miller L, Konrath J, Soper JT, Budwit DA, Creasman WT et al (1986) Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 46(8 Suppl):4244s–4248s

PubMed  Google Scholar 

Alsahafi E, Begg K, Amelio I, Raulf N, Lucarelli P, Sauter T et al (2019) Clinical update on head and neck cancer: molecular biology and ongoing challenges, vol 10. Cell Death and Disease. Nature Publishing Group

Zhao C, Li H, Lin HJ, Yang S, Lin J, Liang G (2016) Feedback activation of STAT3 as a Cancer drug-resistance mechanism. Trends in Pharmacological Sciences, vol 37. Elsevier Ltd, pp 47–61

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S et al (2008) Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer Abstract [Internet]. Vol. 359, N Engl J Med. Available from: www.nejm.org

Koerdel K, Spitzner M, Meyer T, Engels N, Krause F, Gaedcke J et al (2021) NOTCH activation via gp130/STAT3 signaling confers resistance to chemoradiotherapy. Cancers (Basel) 13(3):1–17

Article  Google Scholar 

Ho Choe M, Won Min J, Bae Jeon H, Cho DH, Su Oh J, Gyu Lee H et al ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer [Internet]. Vol. 6. Available from: www.impactjournals.com/oncotarget

Li X, Wang H, Lu X, Di B (2010) Silencing STAT3 with short hairpin RNA enhances radiosensitivity of human laryngeal squamous cell carcinoma xenografts in vivo. Exp Ther Med 1(6):947–953

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fu (2010) Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep 23(3)

Li R, Chen S, Zhan J, Li X, Liu W, Sheng X et al (2020) Long noncoding RNA FOXD2-AS1 enhances chemotherapeutic resistance of laryngeal squamous cell carcinoma via STAT3 activation. Cell Death Dis 11(1)

Feng J, Fan Y, Ayiheng Q, Zhang H, Yong J, Hu B (2017) MicroRNA-125B targeted STAT3 to inhibit laryngeal squamous cell carcinoma cell growth and motility. Oncol Lett 14(1):480–486

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y, Zhang Q, Zhou J, Li Z, Guo J, Wang W et al (2019) Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling. Biosci Rep 39(7)

Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K et al Constitutive Activation of Signal Transducers and Activators of Transcription 3 Correlates with Cyclin D1 Overexpression and May Provide a Novel Prognostic Marker in Head and Neck Squamous Cell Carcinoma 1 [Internet]. Available from: http://aacrjournals.org/cancerres/article-pdf/62/12/3351/2494823/ch1202003351.pdf

Wang W, Sun Y, Li X, Shi X, Li Z, Lu X (2020) Dihydroartemisinin prevents distant metastasis of laryngeal carcinoma by inactivating STAT3 in cancer stem cells. Med Sci Monit 26

Zhao Xdong, Zhang W, Liang H jun, Ji Wyue (2013) Overexpression of miR – 155 promotes Proliferation and Invasion of Human laryngeal squamous cell Carcinoma via Targeting SOCS1 and STAT3. PLoS ONE 8(2)

Pectasides E, Egloff AM, Sasaki C, Kountourakis P, Burtness B, Fountzilas G et al (2010) Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis. Clin Cancer Res 16(8):2427–2434

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gordziel C, Bratsch J, Moriggl R, Knösel T, Friedrich K (2013) Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma. Br J Cancer 109(1):138–146

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monnien F, Zaki H, Borg C, Mougin C, Bosset JF, Mercier M et al (2010) Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial. J Clin Pathol 63(10):873

Article  PubMed  Google Scholar 

Sharma A, Mohanti BK, Thakar A, Bahadur S, Bhasker S (2010) Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial. Ann Oncol 21(11):2272–2277

Article  CAS  PubMed  Google Scholar 

Hato Sv, Figdor CG, Takahashi S, Pen AE, Halilovic A, Bol KF et al (2017) Direct inhibition of STAT signaling by platinum drugs contributes to their anti-cancer activity [Internet]. Vol. 8. Available from: www.impactjournals.com/oncotarget

van Ruitenbeek NJ, van der Woude LL, van Krieken JH, van Engen-van Grunsven ACH, Willemsen AECAB, van Herpen CML (2020) STAT3 as a predictive biomarker in head and neck cancer: a validation study. Pathol Res Pract 216(11)